NeuroMetrix, Inc. | TalkMarkets

Latest Posts

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs

Article By: Benzinga

Sunday, July 18, 2021 11:25 AM EDT

Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks.

In this article: ABT, DGX, JNJ, LLY, NURO, BIIB, ISRG, FGEN, ALBO, MRNA

Read

Debt Free Stocks Selling Below Cash

Article By: Fred Fuld III

Tuesday, December 13, 2016 4:47 AM EDT

Are you looking for stocks that are almost guaranteed not to go out of business? Putting your money into stocks selling below cash is the way to go.

In this article: MSN, NURO, RBCN, OGXI, SPRT, VICL

Read

Week In Review: Week's China Life Science Deals Total $795 Million

Article By: ChinaBio® Today

Saturday, November 19, 2016 2:00 PM EDT

BeyondSpring Pharma, a virtual US-China company, filed to stage a $100 million IPO on the Nasdaq exchange. The company's business plan calls for integrating US and China clinical resources, making adept use of both to reduce cost and time.

In this article: LLY, NURO, SCLN, HCM

Read

Week In Review: BeiGene Schedules $128 Million IPO For February

Article By: ChinaBio® Today

Saturday, January 23, 2016 8:07 PM EDT

News briefs for BeiGene, China's Cocoon Networks, China's iCarbonX, CASI Pharma, Shanghai's WuXI Healthcare Ventures, Hungarian pharma company Gedeon Richter, and Perennial Real Estate Holdings of Singapore.

In this article: CASI, NURO

Read